PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Up 2,135.6% in October

PMGC Holdings Inc. (NASDAQ:ELAB) was the target of a large growth in short interest in October. As of October 15th, there was short interest totaling 427,000 shares, a growth of 2,135.6% from the September 30th total of 19,100 shares. Currently, 63.2% of the shares of the stock are short sold. Based on an average daily volume of 1,170,000 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily volume of 1,170,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 63.2% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

ELAB has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of PMGC in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of PMGC to a “sell” rating in a report on Saturday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

PMGC Trading Down 1.5%

NASDAQ:ELAB opened at $5.95 on Tuesday. The firm has a 50-day moving average price of $5.82 and a two-hundred day moving average price of $7.26. PMGC has a twelve month low of $4.28 and a twelve month high of $514.50. The company has a market capitalization of $4.05 million, a P/E ratio of -0.02 and a beta of 0.32.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.